Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

HB 4702 (2019-2020)

https://ontology.bommaritollc.com/id/01a0d567-0702-72f0-8139-ea2d9cc08474

adms:identifier	mi-legislature-measure 2019-2020/HB/4702
dcterms:temporal	Michigan Legislature, 2019-2020 session
primary sponsor	John Chirkun
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2019-HB-4702 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2019-HB-4702
schema:legislationChanges	MCL 445.911 MCL 445.905 MCL 445.903c MCL 445.903d MCL 445.906 MCL 445.910 MCL 445.908 MCL 445.903n MCL 445.902 MCL 445.922 MCL 445.904 MCL 445.903g MCL 445.903b MCL 445.913 MCL 445.903a MCL 445.915 MCL 445.914 MCL 445.919 MCL 445.921 MCL 445.920 MCL 445.917 MCL 445.918 MCL 445.903e MCL 445.909a MCL 445.912 MCL 445.903m MCL 445.916 MCL 445.903i MCL 445.903f MCL 445.903k MCL 445.909 MCL 445.903o MCL 445.901 MCL 445.907 MCL 445.903l MCL 445.903 MCL 445.903h
schema:legislationIdentifier	HB 4702
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Consumer protection: unfair trade practices; insulin drug pricing report; require by the department of attorney general. Amends 1976 PA 331 (MCL 445.901 - 445.922 ) by adding sec. 9b & repeals sec. 9b of 1976 PA 331 (MCL 445.909b ).en
schema:sponsor	Sara Cambensy John Chirkun
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2019-HB-4702
skos:prefLabel	HB 4702 (2019-2020)en